Spinal muscular atrophy counteracted by Agrin biological NT-1654
Open Access
- 1 January 2018
- journal article
- Published by Heighten Science Publications Corporation in Journal of Neuroscience and Neurological Disorders
- Vol. 2 (1), 011-013
- https://doi.org/10.29328/journal.jnnd.1001009
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA ModelPLOS ONE, 2015
- At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.Current Molecular Medicine, 2013
- Synaptic defects in type I spinal muscular atrophy in human developmentThe Journal of Pathology, 2012
- Therapy Development for Spinal Muscular Atrophy in SMN Independent TargetsNeural Plasticity, 2012
- Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junctionJournal of Cell Science, 2010
- Synaptic Defects in the Spinal and Neuromuscular Circuitry in a Mouse Model of Spinal Muscular AtrophyPLOS ONE, 2010
- Spinal muscular atrophy: mechanisms and therapeutic strategiesHuman Molecular Genetics, 2010
- Review: Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophyNeuropathology and Applied Neurobiology, 2010
- Molecular Functions of the SMN ComplexJournal of Child Neurology, 2007
- Correlation between severity and SMN protein level in spinal muscular atrophyNature Genetics, 1997